Cover Image
市場調查報告書

法國的疾病發生率與患病率

France, Disease Incidence and Prevalence

出版商 Medtech Insight 商品編碼 247874
出版日期 內容資訊 英文 236 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
法國的疾病發生率與患病率 France, Disease Incidence and Prevalence
出版日期: 2014年03月31日 內容資訊: 英文 236 Pages
簡介

歐洲高齡人口的増加與平均壽命變長,預計會讓主要疾病發生率與患病率上升,對於歐州醫療産業有極大的影響。

本報告書為法國的主要障礙/疾病的發生率與患病率之相關調查,與其他歐洲諸國之比較,概述如下。

介紹

第1章 血液障礙

  • 貧血
  • 血友病

第2章 癌

  • 膀胱癌
  • 腦瘍
  • 乳癌
  • 子宮頸/子宮癌
  • 大腸/直腸癌
  • 食道癌
  • 腎臓/尿路上皮癌
  • 白血病
  • 肺癌
  • 淋巴腫
  • 黑色素瘤
  • 口腔癌
  • 卵巢癌
  • 胰臓癌
  • 前立腺癌
  • 胃癌
  • 精巢癌

第3章 心血管疾病

  • 心脈不整
  • 心功能不全
  • 心臓瓣膜症
  • 高血壓
  • 血管障礙

第4章 代謝性疾病

  • 膽石症
  • 慢性腎疾病/末期腎疾病
  • 糖尿病
  • 尿結石症

第5章 肌肉骨骼疾病

  • 關節炎
  • 腕管症候群
  • 半月板與韌帶/肌腱損傷
  • 漸進性肌失養症
  • 骨質疏鬆症

第6章 神經疾病・精神疾病

  • 阿茲海默症・老年癡呆症
  • 肌肉萎縮性側索硬化
  • 雙極性障礙
  • 腦血管疾病
  • 憂鬱症
  • 癲癇
  • 亨廷頓病
  • 水腦症
  • 多發性硬化症
  • 重症筋無力症
  • 帕金森症
  • 精神分裂症

第7章 眼科疾病

  • 白内障
  • 綠内障

第8章 生殖障礙與泌尿生殖器障礙

  • 良性前列腺增生症
  • 子宮内膜症
  • 勃起障礙
  • 不孕
  • 尿失禁

第9章 呼吸系統疾病

  • 急性呼吸窘迫綜合症候群
  • 慢性阻塞性肺疾病與肺氣腫
  • 無呼吸症
  • 氣喘
  • 慢性閉塞性肺疾病
  • 嚢胞性纖維症
  • 氣胸
  • 呼吸不全
  • 拘束性肺疾病

第10章 呼吸系統疾病

  • 急性呼吸窘迫綜合症候群
  • 無呼吸症
  • 喘息
  • 慢性閉塞性肺疾病
  • 嚢胞性纖維症
  • 氣胸
  • 呼吸不全
  • 拘束性肺疾病

第11章 創傷

  • 糖尿病性潰瘍
  • 褥瘡
  • 手術創傷
  • 外傷性創傷

第12章 感染性微生物為原因的主要症狀

  • 慢性支氣管炎
  • 人類免疫不全病毒(HIV)/後天性免疫不全症候群(AIDS)
  • 肺炎
  • 感染性海綿狀腦症(TSE)
  • 結核

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: A710

As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of many major diseases/disorders are expected to increase accordingly and significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the incidence and prevalence of selected diseases/disorders in France. Incidence and prevalence figures are for the year 2012, the most recent year for which data are available.

This report is the first in a series of five reports (Disease Incidence and Prevalence for France, Germany, Italy, Spain, and the United Kingdom) that examine the etiology and epidemiology of the most prevalent and costly diseases/disorders in Europe. Among the topics covered by each of these reports are Alzheimer's disease, anemia, arthritis, asthma, benign prostatic hyperplasia, bronchitis, burns/ traumatic wounds, cancer, depression, diabetes, emphysema, erectile dysfunction, glaucoma, heart failure, human immunodeficiency virus/acquired immune deficiency syndrome, hypertension, infertility, multiple sclerosis, osteoporosis, pneumonia, stroke, and transmissible spongiform encephalopathy.

In addition to proprietary data utilized from Medtech Insight's internal resources, many agencies and organizations have provided information including Alzheimer's Disease International, Association Française des Hémophiles (French Association of Hemophilia), Association France Parkinson, Bladder & Bowel Foundation, Cystic Fibrosis Europe, European Association of Urology, European Cancer Observatory, European Centre for Disease Prevention and Control, European Haemophilia Consortium, European Kidney Health Alliance, European Network for HIV/AIDS Surveillance, European Respiratory Society, European Society of Cardiology, European Tuberculosis Surveillance Network, Fédération Française des Groupements de Parkinsoniens (French Federation of Groups Parkinsonian), French Cystic Fibrosis Association, French Society for Research and Sleep Medicine, International Diabetes Federation, International Glaucoma Association, International Osteoporosis Foundation, Multiple Sclerosis International Federation, Myasthenia Gravis Association, The Schizophrenia Association, Sickle Cell Cure Foundation, World Endometriosis Research Foundation, World Federation of Hemophilia, and the World Health Organization, among others.

Table of Contents

INTRODUCTION

  • Exhibit I-1: France, Selected National Healthcare Statistics

1. BLOOD DISORDERS: ANEMIA AND HEMOPHILIA

  • 1.1 Anemia
    • 1.1.1 Iron Deficiency Anemia
      • 1.1.1.1 Etiology
      • 1.1.1.2 Epidemiology
    • 1.1.2 Sickle Cell Anemia
      • 1.1.2.1 Etiology
      • 1.1.2.2 Epidemiology
    • 1.1.3 Thalassemia
      • 1.1.3.1 Etiology
      • 1.1.3.2 Epidemiology
  • 1.2 Hemophilia
    • 1.2.1 Etiology
    • 1.2.2 Epidemiology
  • Exhibit 1-1: Europe, Estimated Prevalence of Anemia, by Age and Gender
  • Exhibit 1-2: Bleeding Disorders, Worldwide Prevalence, 1999-2011
  • Exhibit 1-3: France, Anemia and Hemophilia, Incidence and Prevalence

2. CANCER

  • 2.1 2.1 Bladder Cancer
    • 2.1.1 Etiology
    • 2.1.2 Epidemiology
  • 2.2 2.2 Brain Tumors
    • 2.2.1 Etiology
    • 2.2.2 Epidemiology
  • 2.3 Breast Cancer
    • 2.3.1 Etiology
    • 2.3.2 Epidemiology
  • 2.4 Cervical/Uterine Cancer
    • 2.4.1 Etiology
    • 2.4.2 Epidemiology
  • 2.5 Colorectal Cancer
    • 2.5.1 Etiology
    • 2.5.2 Epidemiology
  • 2.6 Esophageal Cancer
    • 2.6.1 Etiology
    • 2.6.2 Epidemiology
  • 2.7 Kidney/Urothelial Cancer
    • 2.7.1 Etiology
    • 2.7.2 Epidemiology
  • 2.8 Leukemia
    • 2.8.1 Etiology
    • 2.8.2 Epidemiology
  • 2.9 Lung Cancer
    • 2.9.1 Etiology
    • 2.9.2 Epidemiology
  • 2.10 Lymphoma
    • 2.10.1 Etiology
    • 2.10.2 Epidemiology
  • 2.11 Melanoma
    • 2.11.1 Etiology
    • 2.11.2 Epidemiology
  • 2.12 Oral Cancer
    • 2.12.1 Etiology
    • 2.12.2 Epidemiology
  • 2.13 Ovarian Cancer
    • 2.13.1 Etiology
    • 2.13.2 Epidemiology
  • 2.14 Pancreatic Cancer
    • 2.14.1 Etiology
    • 2.14.2 Epidemiology
  • 2.15 Prostate Cancer
    • 2.15.1 Etiology
    • 2.15.2 Epidemiology
  • 2.16 Stomach Cancer
    • 2.16.1 Etiology
    • 2.16.2 Epidemiology
  • 2.17 Testicular Cancer
    • 2.17.1 Etiology
    • 2.17.2 Epidemiology
  • Exhibit 2-1: France, Selected Cancers, Incidence and Mortality

3. CARDIOVASCULAR DISEASES/DISORDERS

  • 3.1 Cardiac Arrhythmia
    • 3.1.1 Etiology
    • 3.1.2 Epidemiology
  • 3.2 Heart Failure
    • 3.2.1 Etiology
    • 3.2.2 Epidemiology
  • 3.3 Heart Valve Disorders
    • 3.3.1 Etiology
    • 3.3.2 Epidemiology
  • 3.4 Hypertension
    • 3.4.1 Etiology
    • 3.4.2 Epidemiology
  • 3.5 3.5 Vascular Disorders
    • 3.5.1 Aneurysms
      • 3.5.1.1 Etiology
      • 3.5.1.2 Epidemiology
    • 3.5.2 Angina Pectoris
      • 3.5.2.1 Etiology
      • 3.5.2.2 Epidemiology
    • 3.5.3 Atherosclerosis
      • 3.5.3.1 Etiology
      • 3.5.3.2 Epidemiology
    • 3.5.4 Myocardial Infarction
      • 3.5.4.1 Etiology
      • 3.5.4.2 Epidemiology
    • 3.5.5 Peripheral Vascular Disease
      • 3.5.5.1 Etiology
      • 3.5.5.2 Epidemiology
  • Exhibit 3-1: Standard Angina Pectoris Classification
  • Exhibit 3-2: France, Hypercholesterolemia, Prevalence, by Gender and Selected Region
  • Exhibit 3-3: France, Selected Cardiovascular Diseases/Disorders, Incidence and Prevalence

4. METABOLIC DISEASES/DISORDERS

  • 4.1 Cholelithiasis
    • 4.1.1 Etiology
    • 4.1.2 Epidemiology
  • 4.2 Chronic Kidney Disease/End-Stage Renal Disease
    • 4.2.1 Etiology
    • 4.2.2 Epidemiology
  • 4.3 Diabetes
    • 4.3.1 Etiology
    • 4.3.2 Epidemiology
  • 4.4 Urolithiasis
    • 4.4.1 Etiology
    • 4.4.2 Epidemiology
  • Exhibit 4-1: France, Selected Metabolic Diseases/Disorders, Incidence and Prevalence

5. MUSCULOSKELETAL DISEASES/DISORDERS

  • 5.1 Arthritis
    • 5.1.1 Etiology
    • 5.1.2 Epidemiology
  • 5.2 Carpal Tunnel Syndrome
    • 5.2.1 Etiology
    • 5.2.2 Epidemiology
  • 5.3 Meniscal and Ligament/Tendon Injuries
    • 5.3.1 Etiology
    • 5.3.2 Epidemiology
  • 5.4 Muscular Dystrophy
    • 5.4.1 Etiology
    • 5.4.2 Epidemiology
  • 5.5 Osteoporosis
    • 5.5.1 Etiology
    • 5.5.2 Epidemiology
  • Exhibit 5-1: France, Selected Musculoskeletal Diseases/Disorders, Incidence and Prevalence

6. NEUROLOGIC AND PSYCHIATRIC DISEASES/DISORDERS

  • 6.1 Alzheimer's Disease and Dementia
    • 6.1.1 Etiology
    • 6.1.2 Epidemiology
  • 6.2 Amyotrophic Lateral Sclerosis
    • 6.2.1 Etiology
    • 6.2.2 Epidemiology
  • 6.3 Bipolar Disorder
    • 6.3.1 Etiology
    • 6.3.2 Epidemiology
  • 6.4 Cerebrovascular Disorders
    • 6.4.1 Arteriovenous Malformation
      • 6.4.1.1 Etiology
      • 6.4.1.2 Epidemiology
    • 6.4.2 Stroke
      • 6.4.2.1 Etiology
      • 6.4.2.2 Epidemiology
  • 6.5 Depression
    • 6.5.1 Etiology
    • 6.5.2 Epidemiology
  • 6.6 Epilepsy
    • 6.6.1 Etiology
    • 6.6.2 Epidemiology
  • 6.7 Huntington's Disease
    • 6.7.1 Etiology
    • 6.7.2 Epidemiology
  • 6.8 Hydrocephalus
    • 6.8.1 Etiology
    • 6.8.2 Epidemiology
  • 6.9 Multiple Sclerosis
    • 6.9.1 Etiology
    • 6.9.2 Epidemiology
  • 6.10 Myasthenia Gravis
    • 6.10.1 Etiology
    • 6.10.2 Epidemiology
  • 6.11 Parkinson's Disease
    • 6.11.1 Etiology
    • 6.11.2 Epidemiology
  • 6.12 Schizophrenia
    • 6.12.1 Etiology
    • 6.12.2 Epidemiology
  • Exhibit 6-1: Europe, Dementia, Incidence and Prevalence, by Age and Gender
  • Exhibit 6-2: Incidence of Epilepsy per 100,000 Population
  • Exhibit 6-3: France, Selected Neurologic and Psychiatric Diseases/Disorders, Incidence and Prevalence

7. OPHTHALMIC DISORDERS: CATARACTS AND GLAUCOMA

  • 7.1 Cataracts
    • 7.1.1 Etiology
    • 7.1.2 Epidemiology
  • 7.2 Glaucoma
    • 7.2.1 Etiology
    • 7.2.2 Epidemiology
  • Exhibit 7-1: France, Cataracts and Glaucoma, Incidence and Prevalence

8. REPRODUCTIVE AND GENITOURINARY DISORDERS

  • 8.1 8.1 Benign Prostatic Hyperplasia
    • 8.1.1 Etiology
    • 8.1.2 Epidemiology
  • 8.2 Endometriosis
    • 8.2.1 Etiology
    • 8.2.2 Epidemiology
  • 8.3 Erectile Dysfunction
    • 8.3.1 Etiology
    • 8.3.2 Epidemiology
  • 8.4 Infertility
    • 8.4.1 Etiology
    • 8.4.2 Epidemiology
  • 8.5 Urinary Incontinence
    • 8.5.1 Etiology
    • 8.5.2 Epidemiology
  • Exhibit 8-1: France, Selected Reproductive and Genitourinary Disorders, Incidence and Prevalence

9. RESPIRATORY DISEASES/DISORDERS

  • 9.1 Acute Respiratory Distress Syndrome
    • 9.1.1 Etiology
    • 9.1.2 Epidemiology
  • 9.2 Alpha-1 Antitrypsin Deficiency and Emphysema
    • 9.2.1 Etiology
    • 9.2.2 Epidemiology
  • 9.3 Apnea
    • 9.3.1 Etiology
    • 9.3.2 Epidemiology
  • 9.4 Asthma
    • 9.4.1 Etiology
    • 9.4.2 Epidemiology
  • 9.5 Cystic Fibrosis
    • 9.5.1 Etiology
    • 9.5.2 Epidemiology
  • 9.6 Pneumothorax
    • 9.6.1 Etiology
    • 9.6.2 Epidemiology
  • 9.7 Respiratory Failure
    • 9.7.1 Etiology
    • 9.7.2 Epidemiology
  • 9.8 Restrictive Lung Disease
    • 9.8.1 Etiology
    • 9.8.2 Epidemiology
  • Exhibit 9-1: France, Selected Respiratory Diseases/Disorders, Incidence and Prevalence

10. WOUNDS

  • 10.1 Diabetic Ulcers
    • 10.1.1 Etiology
    • 10.1.2 Epidemiology
  • 10.2 Pressure Ulcers
    • 10.2.1 Etiology
    • 10.2.2 Epidemiology
  • 10.3 Surgical Wounds
    • 10.3.1 Etiology
    • 10.3.2 Epidemiology
  • 10.4 Traumatic Wounds
    • 10.4.1 Burns
    • 10.4.2 Head Injuries, Lacerations, Contusions and Abrasions
  • Exhibit 10-1: Contributory Factors for the Development of Pressure Ulcers
  • Exhibit 10-2: France, Diabetic and Pressure Ulcers and Surgical Wounds, Incidence and Prevalence
  • Exhibit 10-3: Classification of Burns, by Mechanism of Injury
  • Exhibit 10-4: France, Burns and Acute Traumatic Injury, Incidence

11. INFECTIOUS DISEASES/DISORDERS

  • 11.1 Chronic Bronchitis
    • 11.1.1 Etiology
    • 11.1.2 Epidemiology
  • 11.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome
    • 11.2.1 Etiology
    • 11.2.2 Epidemiology
  • 11.3 Pneumonia
    • 11.3.1 Etiology
    • 11.3.2 Epidemiology
  • 11.4 Transmissible Spongiform Encephalopathies
    • 11.4.1 Etiology
    • 11.4.2 Epidemiology
  • 11.5 Tuberculosis
    • 11.5.1 Etiology
    • 11.5.2 Epidemiology
  • Exhibit 11-1: Acquired Immune Deficiency Syndrome, Indicator Diseases
  • Exhibit 11-2: France, Selected Infectious Diseases/Disorders, Incidence and Prevalence
Back to Top